Aktienanalyse zu FitLife Brands Inc (FTLF)FTLFFitLife Brands Inc

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Currently, FitLife Brands Inc (FTLF) is not a strong buy due to its low RSI of 37.37, indicating potential oversold conditions, and a significant year-to-date decline of 49.05%. Although there was a recent revenue growth of 65% year-over-year in Q2 2026, the company's gross margin has declined to 36.01%. The upcoming earnings report on November 16, 2026, could provide more clarity, but the current price of $8.03 and the forward P/E of 6.11 suggest caution as the stock is still underperforming.